KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $606,000 | +79.8% | 44,375 | +141.1% | 0.04% | +131.2% |
| Q2 2022 | $337,000 | -23.8% | 18,405 | -33.1% | 0.02% | -36.0% |
| Q1 2022 | $442,000 | -46.7% | 27,506 | -53.5% | 0.02% | -19.4% |
| Q4 2021 | $829,000 | +238.4% | 59,181 | +351.8% | 0.03% | +138.5% |
| Q3 2021 | $245,000 | -82.3% | 13,100 | -80.2% | 0.01% | -78.0% |
| Q2 2021 | $1,382,000 | +77.9% | 66,300 | +141.1% | 0.06% | +37.2% |
| Q1 2021 | $777,000 | – | 27,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |